Full Press Release Details
regeneron and sanofi provide update on dupixent dupilumab sbla for chronic spontaneous urticaria.
REGN
regeneron and sanofi provide update on dupixent dupilumab sbla for chronic spontaneous urticaria
Key Takeaway: regeneron and sanofi provide update on dupixent dupilumab sbla for chronic spontaneous urticaria